|
業務類別
|
Medical Instruments & Supplies |
|
業務概覽
|
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets. |
| 公司地址
| 3950 Johns Creek Court, Suite 100, Suwanee, GA, USA, 30024 |
| 電話號碼
| +1 770 500-3910 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.femasys.com |
| 員工數量
| 54 |
| Mr. John Canning |
Chief Operating Officer |
-- |
01/04/2026 |
| Mr. Dov Elefant |
Chief Financial Officer and Principal Accounting Officer |
美元 432.60K |
31/03/2026 |
| Ms. Kathy Lee-Sepsick |
Director, Chief Executive Officer and President |
美元 542.00K |
31/03/2026 |
| Ms. Christine E. Thomas |
Chief Regulatory and Clinical Officer |
-- |
28/04/2025 |
|
|
| Dr. Kenneth D. Eichenbaum, M.D. |
Independent Director |
20/03/2026 |
| Mr. Edward Uzialko, Jr |
Independent Director |
31/03/2026 |
| Mr. Alistair Milnes |
Independent Director |
31/03/2026 |
| Mr. Charles E. Larsen |
Chairperson of the Board |
31/03/2026 |
| Ms. Kathy Lee-Sepsick |
Director, Chief Executive Officer and President |
31/03/2026 |
|
|
|
|
